BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Czaja AJ. Review article: iron disturbances in chronic liver diseases other than haemochromatosis - pathogenic, prognostic, and therapeutic implications. Aliment Pharmacol Ther 2019;49:681-701. [DOI: 10.1111/apt.15173] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang D, Cao Y, Sun Y, Zhao X, Peng C, Zhao J, Bao X, Wang L, Zhang C. Radiomics nomograms based on R2* mapping and clinical biomarkers for staging of liver fibrosis in patients with chronic hepatitis B: a single-center retrospective study. Eur Radiol 2022. [PMID: 36149481 DOI: 10.1007/s00330-022-09137-z] [Reference Citation Analysis]
2 Gligorijević N, Minić S, Nedić O. Structural changes of proteins in liver cirrhosis and consequential changes in their function. World J Gastroenterol 2022; 28(29): 3780-3792 [DOI: 10.3748/wjg.v28.i29.3780] [Reference Citation Analysis]
3 Hsu CC, Senussi NH, Fertrin KY, Kowdley KV. Iron overload disorders. Hepatol Commun 2022. [PMID: 35699322 DOI: 10.1002/hep4.2012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Dana J, Venkatasamy A, Saviano A, Lupberger J, Hoshida Y, Vilgrain V, Nahon P, Reinhold C, Gallix B, Baumert TF. Conventional and artificial intelligence-based imaging for biomarker discovery in chronic liver disease. Hepatol Int 2022. [PMID: 35138551 DOI: 10.1007/s12072-022-10303-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Trasolini R, Cox B, Galts C, Yoshida EM, Marquez V. Elevated serum ferritin in non-alcoholic fatty liver disease is not predictive of fibrosis. CanLivJ. [DOI: 10.3138/canlivj-2021-0002] [Reference Citation Analysis]
6 Poonkuzhi Naseef P, Elayadeth-Meethal M, Salim K T M, Anjana A, Muhas C, Vajid K A, Saheer Kuruniyan M. Therapeutic Potential Of Induced Iron Depletion Using Iron Chelators In Covid-19. Saudi J Biol Sci 2021. [PMID: 34924800 DOI: 10.1016/j.sjbs.2021.11.061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
7 Viveiros A, Schaefer B, Panzer M, Henninger B, Plaikner M, Kremser C, Franke A, Franzenburg S, Hoeppner MP, Stauder R, Janecke A, Tilg H, Zoller H. MRI-Based Iron Phenotyping and Patient Selection for Next-Generation Sequencing of Non-Homeostatic Iron Regulator Hemochromatosis Genes. Hepatology 2021;74:2424-35. [PMID: 34048062 DOI: 10.1002/hep.31982] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Hino K, Yanatori I, Hara Y, Nishina S. Iron and liver cancer: an inseparable connection. FEBS J 2021. [PMID: 34543507 DOI: 10.1111/febs.16208] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Singal AK, Mathurin P. Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review. JAMA 2021;326:165-76. [PMID: 34255003 DOI: 10.1001/jama.2021.7683] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 26.0] [Reference Citation Analysis]
10 Anderson GJ, Bardou-Jacquet E. Revisiting hemochromatosis: genetic vs. phenotypic manifestations. Ann Transl Med 2021;9:731. [PMID: 33987429 DOI: 10.21037/atm-20-5512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
11 Hernández-Aguilera A, Casacuberta N, Castañé H, Fibla M, Fernández-Arroyo S, Fort-Gallifa I, París M, Sabench F, Del Castillo D, Baiges-Gaya G, Rodríguez-Tomàs E, Sans T, Camps J, Joven J. Nonalcoholic Steatohepatitis Modifies Serum Iron-Related Variables in Patients with Morbid Obesity. Biol Trace Elem Res 2021. [PMID: 33559024 DOI: 10.1007/s12011-021-02610-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Schaapman JJ, Tushuizen ME, Coenraad MJ, Lamb HJ. Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease. J Magn Reson Imaging 2021;53:1623-31. [PMID: 32822095 DOI: 10.1002/jmri.27292] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
13 Himoto T, Masaki T. Current Trends of Essential Trace Elements in Patients with Chronic Liver Diseases. Nutrients 2020;12:E2084. [PMID: 32674425 DOI: 10.3390/nu12072084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
14 Uchida D, Takaki A, Oyama A, Adachi T, Wada N, Onishi H, Okada H. Oxidative Stress Management in Chronic Liver Diseases and Hepatocellular Carcinoma. Nutrients 2020;12:E1576. [PMID: 32481552 DOI: 10.3390/nu12061576] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
15 Guldiken N, Hamesch K, Schuller SM, Aly M, Lindhauer C, Schneider CV, Fromme M, Trautwein C, Strnad P. Mild Iron Overload as Seen in Individuals Homozygous for the Alpha-1 Antitrypsin Pi*Z Variant Does Not Promote Liver Fibrogenesis in HFE Knockout Mice. Cells 2019;8:E1415. [PMID: 31717526 DOI: 10.3390/cells8111415] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
16 Mitchell T, McKinnon E, Ayonrinde O, Adams LA, Trinder D, Chua ACG, Newton RU, Straker L, Olynyk JK. Decreased Physical Working Capacity in Adolescents With Nonalcoholic Fatty Liver Disease Associates With Reduced Iron Availability. Clin Gastroenterol Hepatol 2020;18:1584-91. [PMID: 31628998 DOI: 10.1016/j.cgh.2019.10.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Lal A. Iron in Health and Disease: An Update. Indian J Pediatr 2020;87:58-65. [PMID: 31520313 DOI: 10.1007/s12098-019-03054-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
18 Uhrig M, Mueller J, Longerich T, Straub BK, Buschle LR, Schlemmer HP, Mueller S, Ziener CH. Susceptibility based multiparametric quantification of liver disease: Non-invasive evaluation of steatosis and iron overload. Magn Reson Imaging. 2019;63:114-122. [PMID: 31425813 DOI: 10.1016/j.mri.2019.08.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
19 Gkamprela E, Mani I, Alexopoulou A, Vasilieva L, Pouriki S, Dourakis SP. Letter: high ferritin to haemoglobin ratio is related to early mortality in patients with alcoholic hepatitis. Aliment Pharmacol Ther 2019;49:1456-7. [PMID: 31074902 DOI: 10.1111/apt.15266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Czaja AJ. Letter: high ferritin to haemoglobin ratio is related to early mortality in patients with alcoholic hepatitis - author's reply. Aliment Pharmacol Ther 2019;49:1457-8. [PMID: 31074897 DOI: 10.1111/apt.15275] [Reference Citation Analysis]